Advocacy intelligence hub — real-time data for patient organizations
Dotspace Inc. — NA
OPKO Health, Inc. — PHASE2
Tulavi Therapeutics,Inc.
Shanghai Zhongshan Hospital — NA
Rhode Island Hospital — NA
Second Affiliated Hospital of Nanchang University — NA
Takeda
Alcea — PHASE3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Global Clinical Leader
Daiichi Sankyo
Alain LACHAUX, MD
Hospices Civils de Lyon
Stanislaw R. Burzynski, MD, PhD, M.D., Ph.D
Burzynski Research Institute
📍 HOUSTON, TX
Yanyan Liu, M.D. Ph.D
Henan Cancer Hospital
Yuankai Shi
Chinese Academy of Medical Sciences
Use Central Contact
Astellas Pharma Inc